Real-Time Whole Genome Sequencing to Guide Patient-Tailored Therapy of Severe Acute Respiratory Syndrome Coronavirus

Luke B Snell1, Adela Alcolea-Medina1, Themoula Charalampous1

  • 1Department of Infection, Guy's and St. Thomas' NHS Foundation Trust, London, UK.

Insights

Real-time whole genome sequencing helps manage coronavirus disease 2019 by detecting persistent infections and identifying mutations. This approach guides effective treatment decisions against SARS-CoV-2 variants.

Area of Science:

  • Virology
  • Genomics
  • Infectious Diseases

Background:

  • Coronavirus disease 2019 (COVID-19) management is complicated by numerous therapies.
  • Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and mutations impact treatment efficacy.

Purpose of the Study:

  • To outline the application of real-time whole genome sequencing in COVID-19 management.
  • To demonstrate how sequencing can guide personalized treatment strategies.

Main Methods:

  • Utilizing real-time whole genome sequencing.
  • Detecting persistent SARS-CoV-2 infections.
  • Identifying mutations associated with therapeutic resistance.

Main Results:

  • Real-time sequencing enables timely detection of persistent infections.
  • The method identifies specific mutations conferring resistance to antiviral therapies.
  • Genomic data informs clinical decisions for COVID-19 patients.

Conclusions:

  • Real-time whole genome sequencing is a valuable tool for complex COVID-19 cases.
  • This approach enhances the precision of treatment selection for SARS-CoV-2 infections.
  • Genomic surveillance aids in overcoming challenges posed by viral evolution in treatment.